Search

everythinglearnresearchcommunity

for

Search:↓

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

A woman's shingles infection triggered her first episode of a rare neurological disorder and blood vessel inflammation.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

New treatments for alopecia areata show promise in improving hair loss outcomes.

Some alternative therapies for vitiligo show promise but need more research.

Gray hair can potentially be reversed, leading to new treatments.

A patient experienced intense hair loss due to telogen effluvium after scalp contact dermatitis, but hair regrew completely within two months without further treatment.

Prolactin may be important for skin growth and immune function.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Higher free testosterone levels in men are linked to a stronger immune response, not weaker.

Dermatologists should watch for skin symptoms in COVID-19 patients, prioritize urgent cases, and use telemedicine.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Corticosteroid injections are the most effective treatment for alopecia areata.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Two siblings both had a rare case of alopecia areata at the same time.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Pediatric pemphigus is often diagnosed late, but rituximab helps control it long-term.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Alopecia areata is an autoimmune condition causing patchy hair loss, with treatments focusing on immune system regulation and hair regrowth.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Managing skin diseases during pregnancy and postpartum requires careful consideration of treatment safety and dosing to protect both mother and baby.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.